Prime Medicine PRME
NASDAQ PRME
$3.08 -0.01 (-0.32%)
As of: Sep 30, 2026 · 3:40 PM EDT

Prime Medicine (PRME) Capital Expenditures (2021 - 2026)

Updated

Prime Medicine (PRME) recorded Capital Expenditures of $46,000 in Q2 2026, down 97.1% from $1.57 million a year earlier and down 78.5% from the prior quarter.

Analysis

Prime Medicine (PRME) Capital Expenditures (2021 - 2026) Analysis & Trends

On a TTM basis, Prime Medicine's Capital Expenditures came in at $797,000 as of Jun 30, 2026, down 88.7% year-over-year; for FY2025, it came in at $4.53 million, down 37.9% from FY2024.

  • Annual Capital Expenditures has declined for three straight years, though with a five-year compound annual growth rate of 48.0% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $7.29 million in FY2024 (-16.4%), $8.72 million in FY2023 (-45.8%), $16.1 million in FY2022 (+287.8%) and $4.15 million in FY2021 (+549.5%).
  • The Q2 2026 figure is the lowest quarterly Capital Expenditures in data going back to Q4 2021.
  • On a year-over-year basis, Capital Expenditures has declined for five consecutive quarters, with an average decline of 53.1% over the last eight quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 18.4% in Q1 2023, against a decline of 97.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $214,000 (Q1 2026), $290,000 (Q4 2025) and $247,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Prime Medicine 558.48 Mn 558.48 Mn - 46,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,000.00
Mar 31, 2026 214,000.00
Dec 31, 2025 290,000.00
Sep 30, 2025 247,000.00
Jun 30, 2025 1.57 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 1.79 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 1.90 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 1.84 Mn
Sep 30, 2023 2.91 Mn
Jun 30, 2023 1.98 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 4.81 Mn
Sep 30, 2022 4.79 Mn
Jun 30, 2022 4.80 Mn
Mar 31, 2022 1.69 Mn
Dec 31, 2021 382,000.00
API Access

Prime Medicine Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRME&period=max&api_key=YOUR_API_KEY